How Much Does Avodart (Dutasteride) Cost in Alaska in 2026?

Alaska Retail Pricing: Brand vs. Generic Dutasteride

The price gap between brand Avodart and generic dutasteride is enormous. GSK lists brand Avodart at approximately $290 for a 30-day supply, a figure that has climbed steadily since the drug's FDA approval in 2001 for symptomatic BPH [1]. Generic dutasteride 0.5 mg capsules, available since patent expiry in 2015, average about $25 per month across Alaska retail pharmacies in 2026.

That pricing reflects a common pattern with 5-alpha reductase inhibitors. Once generics entered the market, cash-pay costs dropped by more than 90%. Alaska's smaller pharmacy market, concentrated in Anchorage, Fairbanks, and Juneau, can show wider price swings between locations than you would see in the Lower 48. Checking prices at multiple pharmacies or using a discount card before filling is worth the few minutes it takes.

Wholesale acquisition cost for generic dutasteride sits below $10 per month at many distributors. Retail markup and dispensing fees account for the difference between that figure and the $25 average patients actually pay. Rural Alaska pharmacies with higher operating costs may charge $30 to $35 for the same generic supply [2].

Alaska Medicaid Does Not Cover Dutasteride

Alaska Medicaid does not include Avodart or generic dutasteride on its preferred drug list. This applies to the BPH indication and to any off-label use, including androgenetic alopecia.

Patients enrolled in Denali KidCare or other Medicaid-managed plans in Alaska face the same exclusion. A prior authorization request could theoretically be submitted, but approvals for dutasteride through Alaska Medicaid are rare and typically denied when alternatives like tamsulosin (an alpha-blocker) remain on formulary. The AUA Guidelines on BPH management recommend 5-alpha reductase inhibitors for men with prostate volumes greater than 30 mL, but Medicaid programs are not obligated to cover every guideline-recommended option when cheaper therapeutic alternatives exist [3].

If you are on Alaska Medicaid and your prescriber believes dutasteride is medically necessary, ask them to file a formal coverage determination with clinical documentation of prostate volume and prior alpha-blocker failure. Success rates for these appeals are low but not zero.

Private Insurance Coverage in Alaska

Most commercial health plans in Alaska, including those offered through Premera Blue Cross Blue Shield of Alaska and Moda Health, cover generic dutasteride with a Tier 2 or Tier 3 copay. That typically means $10 to $40 per month depending on your specific plan and deductible status.

Brand Avodart sits on Tier 3 or the non-preferred brand tier for nearly all Alaska insurers. Copays for brand range from $50 to $75, and some plans require step therapy through generic dutasteride or finasteride first. According to the Endocrine Society's clinical practice guidelines, 5-alpha reductase inhibitors are a standard pharmacologic intervention, which supports coverage arguments when dealing with plan denials [4].

Federal employees in Alaska covered by FEHB plans and Tricare beneficiaries stationed at Joint Base Elmendorf-Richardson or Eielson Air Force Base generally have dutasteride covered through their respective formularies. Tricare covers generic dutasteride at the $12 copay tier for a 30-day retail fill, or $0 through the mail-order pharmacy.

Compounded Dutasteride in Alaska: Legal and Available

Compounded dutasteride is legal in Alaska through 503A-licensed compounding pharmacies. These pharmacies operate under a valid prescription from a licensed prescriber and compound the medication per patient-specific orders, in compliance with the FDA's compounding guidance under Section 503A of the FD&C Act [5].

Typical cost for compounded dutasteride in Alaska runs about $40 per month. That is higher than generic retail pricing, so compounding makes most financial sense when a patient needs a non-standard dose, a topical formulation, or a combination product (such as dutasteride combined with minoxidil for hair loss). Some compounding pharmacies ship to Alaska addresses from facilities in other states, which is permitted as long as the pharmacy holds appropriate licensure.

The Alaska Board of Pharmacy requires that 503A pharmacies compounding for Alaska patients either hold an Alaska pharmacy license or operate under a valid non-resident pharmacy license. Always verify your compounding pharmacy's license status through the Alaska Department of Commerce, Community, and Economic Development before ordering.

Telehealth Prescribing: How to Get Dutasteride in Alaska Remotely

Alaska permits telehealth prescribing of dutasteride statewide. This matters in a state where the nearest urologist might be a 400-mile flight away.

A prescriber licensed in Alaska (or holding a valid interstate medical licensure compact credential) can evaluate a patient via synchronous video or audio-only visit and prescribe dutasteride without an in-person exam, provided they establish an appropriate patient-provider relationship. The AUA's position statement on telemedicine supports remote management of BPH, including 5-alpha reductase inhibitor prescribing, when clinical criteria are met [3].

HealthRX and similar telehealth platforms can connect Alaska residents with licensed prescribers who evaluate symptoms, review labs (including PSA), and prescribe dutasteride with the medication shipped directly to your door. For patients in Bethel, Nome, Kodiak, or other remote communities, telehealth eliminates the travel burden entirely.

How Dutasteride Works and Why Pricing Matters for Long-Term Use

Dutasteride inhibits both type I and type II isoforms of 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). This dual inhibition reduces serum DHT by approximately 90% at steady state, compared to roughly 70% reduction with finasteride, which blocks only the type II isoform [1][6].

For BPH, the CombAT trial (N=4,844) demonstrated that dutasteride combined with tamsulosin reduced the relative risk of acute urinary retention or BPH-related surgery by 65.8% compared to tamsulosin alone over 4 years [7]. Dr. Claus Roehrborn, lead investigator on CombAT, stated: "Combination therapy with dutasteride and tamsulosin provides a significant and sustained reduction in clinical progression of BPH compared with either monotherapy" [7].

For male pattern hair loss, Eun et al. conducted a randomized investigator-blinded trial (N=153) comparing dutasteride 0.5 mg to finasteride 1 mg daily over 24 weeks. Dutasteride produced significantly greater increases in total hair count and terminal hair count in the target area (p<0.01 for both endpoints) [2]. That superior DHT suppression translates to a measurable clinical difference in hair density.

Because both conditions require continuous daily dosing, cost over years adds up fast. A patient paying $25 per month for generic dutasteride spends $300 per year. At the brand price of $290 per month, that same patient would spend $3,480 annually. Over a 10-year treatment course, the difference is $31,800.

Discount Programs and Savings Strategies for Alaska Residents

Several pathways can lower your out-of-pocket cost for dutasteride in Alaska.

GSK Savings Card. GSK offers a manufacturer savings card for brand Avodart that can reduce copays to as low as $15 per month for commercially insured patients. The card does not apply to government insurance programs (Medicaid, Medicare, Tricare, VA). Eligible patients can enroll through GSK's patient assistance portal. The card covers up to a defined annual maximum, typically $1,500 to $2,000 per year in savings.

Pharmacy discount programs. GoodRx, RxSaver, and similar aggregators often list generic dutasteride below $15 per month at Alaska chain pharmacies including Costco, Fred Meyer, and Walmart. Costco does not require a membership for pharmacy purchases. Prices fluctuate, so checking the day you fill is the best approach.

Mail-order pharmacies. Mail-order fills through Mark Cuban's Cost Plus Drugs or Amazon Pharmacy can bring generic dutasteride below $10 per month, even with shipping to Alaska addresses. The FDA supports legitimate mail-order pharmacy operations as long as they are properly licensed [5].

Patient assistance programs. Uninsured patients with household income below 300% of the federal poverty level may qualify for GSK's Patient Assistance Program, which provides brand Avodart at no cost. Application requires prescriber involvement and income verification.

Side Effects and Monitoring Considerations

The FDA-approved prescribing information for dutasteride lists the most common adverse reactions as impotence (4.7%), decreased libido (3.0%), ejaculation disorders (1.4%), and gynecomastia (1.3%) in BPH clinical trials [1]. Most sexual side effects occurred within the first 6 months and resolved in many patients who continued therapy.

Dutasteride reduces serum PSA by approximately 50% after 6 months of treatment. The 2023 AUA/ASTRO guideline on early detection of prostate cancer advises clinicians to double the measured PSA value in patients taking a 5-alpha reductase inhibitor to estimate the true PSA level [3]. Any confirmed PSA rise while on dutasteride warrants urologic evaluation, even if the absolute number appears low.

Dr. Kevin McVary, former chair of the AUA BPH Guidelines Panel, has noted: "Clinicians prescribing 5-alpha reductase inhibitors must adjust their interpretation of PSA and counsel patients about the expected 50% reduction to avoid missed diagnoses" [3].

Dutasteride has a long half-life of approximately 5 weeks at steady state. Blood donation is restricted for 6 months after the last dose due to the risk of exposure to pregnant women through transfusion. Women who are or may become pregnant should not handle damaged or opened dutasteride capsules, as the drug can be absorbed through the skin and may cause birth defects in male fetuses [1].

Dutasteride vs. Finasteride: Cost and Efficacy in Alaska

Generic finasteride 1 mg (for hair loss) or 5 mg (for BPH) costs roughly $5 to $10 per month in Alaska, making it the cheaper option. Clinical efficacy data, however, favors dutasteride for both indications.

In the Eun et al. trial, dutasteride 0.5 mg produced a mean increase of 12.2 hairs/cm² in target area hair count versus 4.7 hairs/cm² for finasteride 1 mg at 24 weeks (p<0.005) [2]. For BPH, the EPICS trial (N=1,630) found comparable symptom improvement between dutasteride and finasteride at 12 months, though dutasteride achieved greater DHT suppression [8].

The choice between the two drugs involves balancing a $15 to $20 per month cost difference against the degree of DHT suppression your clinical situation requires. Patients with large prostates (volume >40 mL) or aggressive androgenetic alopecia may benefit more from dutasteride's dual-isoform blockade. Patients with milder symptoms or tighter budgets often do well with finasteride.

Your prescriber can help determine which 5-alpha reductase inhibitor fits your clinical profile, and switching between them is straightforward if the first choice does not produce adequate results within 6 to 12 months.